COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 852: Articles 8511-8520  | Next

SARS-CoV-2 Spike evolution influences GBP and IFITM sensitivity
Mesner, D., Reuschl, A.-K., Whelan, M. V. X., Bronzovich, T., Haider, T., Thorne, L. G., Towers, G. J., Jolly, C.
10.1101/2022.03.07.481785 — Posted: 2022-03-07
Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
Wills, N. K., Nair, N., Patel, K., Sikder, O., Adriaanse, M., Eikelboom, J., Wasserman, S.
10.1101/2022.03.05.22271947 — Posted: 2022-03-07
A new compartment model of COVID-19 transmission: The broken-link model
Ikeda, Y., Sasaki, K., Nakano, T.
10.1101/2022.03.04.22271940 — Posted: 2022-03-07
Social capital, urbanization level, and COVID-19 vaccination uptake in the United States: A national level analysis
Qiao, S., Li, Z., Zhang, J., Sun, X., Garrett, C., Li, X.
10.1101/2022.03.04.22271917 — Posted: 2022-03-07
The mutational steps of SARS-CoV-2 to become like Omicron within seven months: the story of immune escape in an immunocompromised patient.
Sonnleitner, S. T., Prelog, M., Sonnleitner, S., Hinterbichler, E., Halbfurter, H., Kopecky, D., Almanzar, G., Koblmueller, S., Sturmbauer, C., Feist, L., Horres, R., Posch, W., Walder, G.
10.1101/2022.03.04.22271540 — Posted: 2022-03-07
Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine
Naaber, P., Tserel, L., Kangro, K., Sepp, E., Jurjenson, V., Karner, J., Haljasmagi, L., Haljasorg, U., Kuusk, M., Gerhold, J. M., Planken, A., Ustav, M., Kisand, K., Peterson, P.
10.1101/2022.03.04.22271890 — Posted: 2022-03-07
Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis
Murison, K., Grima, A., Simmons, A., Tuite, A., Fisman, D.
10.1101/2022.03.04.22271915 — Posted: 2022-03-07
Social connections at work and mental health during the first wave of the COVID-19 pandemic: Evidence from employees in Germany
Breetzke, J., Wild, E.-M.
10.1101/2022.03.04.22270966 — Posted: 2022-03-07
A rapid review of the effectiveness of alternative education delivery strategies in medical, dental, nursing and pharmacy education during the COVID-19 pandemic
Carrier, J., Edwards, D., Tombs, M., Lewis, R., Gillen, E., Riley, S., Cooper, A., Edwards, A.
10.1101/2022.03.04.22271892 — Posted: 2022-03-07
A systematic review about skin lesions in children affected by Coronavirus Disease 2019 (excluding multisystem inflammatory syndrome in children): study protocol.
Dondi, A., Sperti, G., Gori, D., Montalti, M., Parini, L., Guaraldi, F., Lanari, M., Neri, I.
10.1101/2022.03.04.22271888 — Posted: 2022-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).